These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 7613152)

  • 1. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
    Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1995; 107(1-3):290-4. PubMed ID: 7613152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.
    Vrtala S; Mayer P; Ferreira F; Susani M; Sehon AH; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):913-21. PubMed ID: 8939154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2.
    Ferreira FD; Mayer P; Sperr WR; Valent P; Seiberler S; Ebner C; Liehl E; Scheiner O; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):95-103. PubMed ID: 8568143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles.
    Rossi RE; Monasterolo G; Monasterolo S
    Allergy; 2003 Sep; 58(9):929-32. PubMed ID: 12911423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
    Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How far can we simplify in vitro diagnostics for Fagales tree pollen allergy? A study with three whole pollen extracts and purified natural and recombinant allergens.
    Van Ree R; Van Leeuwen WA; Akkerdaas JH; Aalberse RC
    Clin Exp Allergy; 1999 Jun; 29(6):848-55. PubMed ID: 10336603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin).
    Ebner C; Hirschwehr R; Bauer L; Breiteneder H; Valenta R; Ebner H; Kraft D; Scheiner O
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):962-9. PubMed ID: 7751517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
    Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
    Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
    Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
    J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergens from birch pollen and pollen of the European chestnut share common epitopes.
    Hirschwehr R; Jäger S; Horak F; Ferreira F; Valenta R; Ebner C; Kraft D; Scheiner O
    Clin Exp Allergy; 1993 Sep; 23(9):755-61. PubMed ID: 10779306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
    Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
    Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP system in patients with pollen-related allergy to birch and apple.
    Rossi RE; Monasterolo G; Operti D; Corsi M
    Allergy; 1996 Dec; 51(12):940-5. PubMed ID: 9020425
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
    Front Immunol; 2020; 11():2118. PubMed ID: 33013894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen.
    Wiedermann U; Jahn-Schmid B; Fritsch R; Bauer L; Renz H; Kraft D; Ebner C
    Clin Exp Immunol; 1998 Jan; 111(1):144-51. PubMed ID: 9472674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies.
    Pauli G; Oster JP; Deviller P; Heiss S; Bessot JC; Susani M; Ferreira F; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 May; 97(5):1100-9. PubMed ID: 8626988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1.
    Mahler V; Vrtala S; Kuss O; Diepgen TL; Suck R; Cromwell O; Fiebig H; Hartl A; Thalhamer J; Schuler G; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Jan; 34(1):115-22. PubMed ID: 14720271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy.
    Ganglberger E; Barbara Sponer ; Schöll I; Wiedermann U; Baumann S; Hafner C; Breiteneder H; Suter M; Boltz-Nitulescu G; Scheiner O; Jensen-Jarolim E
    FASEB J; 2001 Nov; 15(13):2524-6. PubMed ID: 11641259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance.
    Wensing M; Akkerdaas JH; van Leeuwen WA; Stapel SO; Bruijnzeel-Koomen CA; Aalberse RC; Bast BJ; Knulst AC; van Ree R
    J Allergy Clin Immunol; 2002 Sep; 110(3):435-42. PubMed ID: 12209091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.